Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6363438rdf:typepubmed:Citationlld:pubmed
pubmed-article:6363438lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6363438lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:6363438lifeskim:mentionsumls-concept:C0017725lld:lifeskim
pubmed-article:6363438lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:6363438lifeskim:mentionsumls-concept:C0332479lld:lifeskim
pubmed-article:6363438lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:6363438lifeskim:mentionsumls-concept:C1149501lld:lifeskim
pubmed-article:6363438lifeskim:mentionsumls-concept:C0683162lld:lifeskim
pubmed-article:6363438lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:6363438lifeskim:mentionsumls-concept:C1707797lld:lifeskim
pubmed-article:6363438pubmed:issue2lld:pubmed
pubmed-article:6363438pubmed:dateCreated1984-3-5lld:pubmed
pubmed-article:6363438pubmed:abstractTextTo determine the influence of insulin infusions used in dose-response studies on monocyte insulin binding, monocyte insulin binding and glucose disposal were measured in six normal subjects before and at the end of each of four sequential 2-h insulin infusions (0.4, 1.0, 2.0, and 10 mU kg-1 min-1). Monocyte insulin binding was unaltered at the end of the first three infusions (plasma insulin, 31 +/- 2 (SEM), 77 +/- 3, and 184 +/- 10 microU/ml) but was decreased after the last infusion (plasma insulin, 1730 +/- 125 microU/ml) at 0.2 through 10.2 ng/ml insulin concentrations in the binding assay (P less than 0.01). Using a one-site model, this could be ascribed to a decrease in insulin receptor affinity (1.54 +/- 0.26 vs. 2.27 +/- 0.48 X 10(8) M-1, P less than 0.05), whereas in a two-site model this appeared to be due to a decrease in high affinity binding sites (1,868 +/- 228 vs. 2,387 +/- 207, P less than 0.02). Nevertheless, insulin receptor occupancies estimated to occur during the insulin infusions were virtually identical whether preinsulin infusion binding data (745 +/- 72, 1,383 +/- 117, 2,572 +/- 302, and 10,092 +/- 1,708) or binding data at the end of each infusion (702 +/- 56, 1,367 +/- 150, 2,383 +/- 318, and 9,158 +/- 2,023) were used to calculate occupancy. These results indicate that although monocyte insulin binding decreased during dose-response experiments using sequential infusions of insulin, due to the concentrations of insulin at which this occurs this decrease did not alter the shape of the dose-response curve relating glucose disposal to monocyte insulin receptor occupancy.lld:pubmed
pubmed-article:6363438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363438pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363438pubmed:languageenglld:pubmed
pubmed-article:6363438pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363438pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6363438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363438pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6363438pubmed:statusMEDLINElld:pubmed
pubmed-article:6363438pubmed:monthFeblld:pubmed
pubmed-article:6363438pubmed:issn0021-972Xlld:pubmed
pubmed-article:6363438pubmed:authorpubmed-author:BakerBBlld:pubmed
pubmed-article:6363438pubmed:authorpubmed-author:GerichJJlld:pubmed
pubmed-article:6363438pubmed:authorpubmed-author:RizzaRRlld:pubmed
pubmed-article:6363438pubmed:authorpubmed-author:BrickBBlld:pubmed
pubmed-article:6363438pubmed:authorpubmed-author:MandarinoLLlld:pubmed
pubmed-article:6363438pubmed:issnTypePrintlld:pubmed
pubmed-article:6363438pubmed:volume58lld:pubmed
pubmed-article:6363438pubmed:ownerNLMlld:pubmed
pubmed-article:6363438pubmed:authorsCompleteYlld:pubmed
pubmed-article:6363438pubmed:pagination392-6lld:pubmed
pubmed-article:6363438pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:meshHeadingpubmed-meshheading:6363438-...lld:pubmed
pubmed-article:6363438pubmed:year1984lld:pubmed
pubmed-article:6363438pubmed:articleTitleInfluence of changes in insulin receptor binding during insulin infusions on the shape of the insulin dose-response curve for glucose disposal in man.lld:pubmed
pubmed-article:6363438pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6363438pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6363438pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed